FDA approves Zepbound® (tirzepatide) as the first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity ...Middle East

Averaging up to 20% of weight loss, adults taking Zepbound had at least 25 fewer breathing interruptions each hour as they slept Up to 50% of adults taking Zepbound no longer had symptoms associated with OSA after one year INDIANAPOLIS, Dec. 20, 2024 /PRNewswire/ -- Eli Lilly and Company...

Hence then, the article about fda approves zepbound tirzepatide as the first and only prescription medicine for moderate to severe obstructive sleep apnea in adults with obesity was published today ( Saturday 21/12/2024 - 12:38 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA approves Zepbound® (tirzepatide) as the first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity )

Also on site :

• Lisa Kudrow Gets Brutally Honest About ‘Friends’ Fame
• 2000s Heavy Metal Rocker Makes $1.5 Million Move Before 2026 Tour
• Iran strikes fully loaded Kuwaiti oil tanker at Dubai port; spill risk flagged